Abstract
We report here paired isogenic Burkholderia pseudomallei genomes obtained from three patients receiving intravenous meropenem for melioidosis treatment, with post-meropenem isolates developing decreased susceptibility. Two genomes were finished, and four were drafted to improved high-quality standard. These genomes will be used to identify meropenem resistance mechanisms in B. pseudomallei.
Original language | English |
---|---|
Article number | e00053-17 |
Pages (from-to) | 1-3 |
Number of pages | 3 |
Journal | Genome Announcements (genomeA) |
Volume | 5 |
Issue number | 14 |
DOIs | |
Publication status | Published - Apr 2017 |